Global Manufacturing of CAR T Cell Therapy

Immunotherapy using chimeric antigen receptor-modified T cells has demonstrated high response rates in patients with B cell malignancies, and chimeric antigen receptor T cell therapy is now being investigated in several hematologic and solid tumor types. Chimeric antigen receptor T cells are generat...

Descripción completa

Detalles Bibliográficos
Autores principales: Levine, Bruce L., Miskin, James, Wonnacott, Keith, Keir, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363291/
https://www.ncbi.nlm.nih.gov/pubmed/28344995
http://dx.doi.org/10.1016/j.omtm.2016.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363291/
https://www.ncbi.nlm.nih.gov/pubmed/28344995
http://dx.doi.org/10.1016/j.omtm.2016.12.006

Ejemplares similares